Indication

For treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age

Medicine details

Medicine name:
linzagolix (Yselty)
SMC ID:
SMC2631
Pharmaceutical company
Theramex UK LTD
BNF chapter
Obstetrics, gynaecology, and urinary-tract disorders
Submission type
Full
Publication due date:
11 November 2024
SMC meeting date:
02 April 2024
Patient group submission deadline:
TBC